clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT02290002 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
phase III clinical trial | Q42824827 | ||
P17 | country | Egypt | Q79 |
P582 | end time | 2016-12-01 | |
P4135 | maximum age | 45 | |
P1050 | medical condition | infertility | Q179399 |
ovarian hyperstimulation syndrome | Q1760461 | ||
P2899 | minimum age | 23 | |
P1132 | number of participants | 200 | |
P4844 | research intervention | calcium oxalate | Q412399 |
calcium dobesilate | Q5018825 | ||
P580 | start time | 2014-06-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome |